Other Health

Kinos Medical Merges with restor3d

Saturday, May 15, 2021 - 1:42am

b'restor3d is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.\nrestor3d (Durham, NC), a leader in patient-specific 3D printed implants, is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.

Key Points: 
  • b'restor3d is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.\nrestor3d (Durham, NC), a leader in patient-specific 3D printed implants, is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.
  • restor3d (Durham, NC), was founded with a mission to enable surgeons to repair and reconstruct the human body using 3D printing technologies, advanced biomaterials, and artificial intelligence.
  • The Axiom total ankle is the first biomechanically accurate implant on the market, offering motion in all three anatomic planes, as is seen in the natural ankle,\xe2\x80\x9d said Brian Garvey, CEO of Kinos Medical.
  • Leveraging expertise and experience in 3D printing of key biomedical materials spanning a wide range of properties, restor3d seeks to improve medical device solutions.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005572/en/\n'

“A Global Pandemic Treaty to Deliver Security for Us All”: A Virtual Press Conference 9:30-10:30 a.m. ET, May 18, 2021, Hosted by the GPHC Panel

Friday, May 14, 2021 - 11:09pm

b'The Panel for a Global Public Health Convention ( GPHC ) will hold a virtual press conference at the Washington-based National Press Club to highlight gaps in the ongoing international debate about what a global pandemic treaty or convention should look like and what must be done to ensure robust compliance and buy-in among countries.\nFounded in 2020, the Panel is an independent coalition of global leaders working to strengthen the world\xe2\x80\x99s ability to prevent, prepare, and respond to pandemics.

Key Points: 
  • b'The Panel for a Global Public Health Convention ( GPHC ) will hold a virtual press conference at the Washington-based National Press Club to highlight gaps in the ongoing international debate about what a global pandemic treaty or convention should look like and what must be done to ensure robust compliance and buy-in among countries.\nFounded in 2020, the Panel is an independent coalition of global leaders working to strengthen the world\xe2\x80\x99s ability to prevent, prepare, and respond to pandemics.
  • Its aim is to reform the global public health architecture by promulgating a new health treaty to avert and prepare for future pandemics.\nLawrence Gostin, Professor of Global Health Law, Georgetown University\nJOIN: Register here for the virtual press conference.\nThe Panel is chaired by Dame Barbara Stocking, President of Murray Edwards College, Cambridge and former chief executive of Oxfam GB.
  • This study was conducted by the University of Miami with the support of the AIDS Healthcare Foundation.
  • After the research team gathered and analyzed input from 29 public health thought leaders, it distilled this information into a list of 10 recommendations on what must be done to reform the global public health system to avoid another disastrous pandemic.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005563/en/\n'

Greenbrook TMS Reports First Quarter Operational and Financial Results

Friday, May 14, 2021 - 10:01pm

TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation.

Key Points: 
  • TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation.
  • In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information.
  • Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management\xe2\x80\x99s perspective.
  • In addition to our results determined in accordance with IFRS, we use non-IFRS measures including, \xe2\x80\x9cEBITDA\xe2\x80\x9d and \xe2\x80\x9cAdjusted EBITDA\xe2\x80\x9d.

Dermatology Diagnostic Devices Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Friday, May 14, 2021 - 6:04pm

b'The "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global dermatology diagnostic devices market reached a value of US$ 26.1 Billion in 2020.\nDermatology is the field of medicine which involves the study, diagnosis and treatment of skin diseases.

Key Points: 
  • b'The "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global dermatology diagnostic devices market reached a value of US$ 26.1 Billion in 2020.\nDermatology is the field of medicine which involves the study, diagnosis and treatment of skin diseases.
  • Generally, the diagnosis is performed through a visual examination, followed by microscopic observation of the skin which helps in identifying the disease and specifying a treatment plan.
  • Looking forward, the publisher expects the global dermatology diagnostic devices market exhibit moderate growth during the next five years.\nGlobal Dermatology Diagnostic Devices Market Drivers:\nVarious pollutants including polycyclic aromatic hydrocarbons, oxides and ultraviolet radiation cause damage to the skin by inducing oxidative stress.
  • They are also introducing devices that are smaller and easier to use.\nKey Questions Answered in This Report:\nHow has the global dermatology diagnostic devices market performed so far and how will it perform in the coming years?\nWhat are the key regional markets in the global dermatology diagnostic devices industry?\nWhat has been the impact of COVID-19 on the global dermatology diagnostic devices industry?\nWhat is the breakup of the global dermatology diagnostic devices market on the basis of product type?\nWhat is the breakup of the global dermatology diagnostic devices market on the basis of end-use?\nWhat are the various stages in the value chain of the global dermatology diagnostic devices market?\nWhat are the key driving factors and challenges in the global dermatology diagnostic devices market?\nWhat is the structure of the global dermatology diagnostic devices market and who are the key players?\nWhat is the degree of competition in the global dermatology diagnostic devices market?\n'

Global Joint Pain Injection Market (2021 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Friday, May 14, 2021 - 5:38pm

However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.

Key Points: 
  • However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.
  • Sports injuries are caused due to direct impact or due to the application of force that is larger than the body part can withstand.
  • Thus, the growing number of sport injuries is boosting the demand for joint pain injections.\nBased on joint type, the joint pain injection market is segmented into knee, shoulder and elbow, hip, foot and ankle, and others.
  • In 2020, the knee joint type segment accounted for the largest share of the market.

Global Healthcare/Medical Simulation Market Trajectory & Analytics to 2027 - ResearchAndMarkets.com

Friday, May 14, 2021 - 5:15pm

b'Table 1: World Current & Future Analysis for Healthcare/Medical Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Healthcare Anatomical Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Web-based Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Healthcare Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Simulation Training Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Military Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\n'

Key Points: 
  • b'Table 1: World Current & Future Analysis for Healthcare/Medical Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Healthcare Anatomical Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Web-based Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Healthcare Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Simulation Training Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Military Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\nWorld Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR\n'

Somnology Wins “Best Sleep Monitoring Solution” Award in 2021 MedTech Breakthrough Awards Program

Friday, May 14, 2021 - 5:15pm

Specialists analyze droves of data, processed through the platform, to isolate biometric patterns indicative of sleep disorders.

Key Points: 
  • Specialists analyze droves of data, processed through the platform, to isolate biometric patterns indicative of sleep disorders.
  • \xe2\x80\x9cAnd with 70 million people affected by sleep disorders and a limited 7,500 board certified sleep physicians, the process of actual diagnosis is a challenge.
  • Somnology is dedicated to creating mobile, interactive solutions that empower patients to get the best night\xe2\x80\x99s sleep for health and optimum performance.
  • For more information about Somnology, visit www.somnologymd.com .\nPart of Tech Breakthrough , a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people.

Optime Care Calls for Greater Awareness of Hereditary Angioedema, Highlights Patient-First Strategy for Treatment and Optimized Care, Recognizes May 16, hae day :-)

Friday, May 14, 2021 - 4:04pm

The campaign brings greater understanding of the disease to the general public, healthcare professionals, healthcare decision makers and industry representatives around the world.

Key Points: 
  • The campaign brings greater understanding of the disease to the general public, healthcare professionals, healthcare decision makers and industry representatives around the world.
  • Optime Care\xe2\x80\x99s patient-first approach impacts the burdens of living with HAE by tailoring a proactive service experience for each patient.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210514005392/en/\n\xe2\x80\x9cAccess to innovative therapies that can improve quality of life is critical for people with rare diseases like HAE,\xe2\x80\x9d said Donovan Quill, president and CEO, Optime Care.
  • They motivate and encourage me, and they have helped me grow into the best care coordinator I can be.

$741.4 Million Worldwide Liver Health Supplements Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

Friday, May 14, 2021 - 3:59pm

China, the world\'s second largest economy, is forecast to reach a projected market size of US$201.8 Million by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027.

Key Points: 
  • China, the world\'s second largest economy, is forecast to reach a projected market size of US$201.8 Million by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.3% respectively over the 2020-2027 period.
  • These regional markets accounting for a combined market size of US$61.1 Million in the year 2020 will reach a projected size of US$79.8 Million by the close of the analysis period.
  • China will remain among the fastest growing in this cluster of regional markets.

Oncology and Hematology Specialists, P.A. and Deep Lens Partner to Integrate Clinical Trial Matching Solution VIPER™ Into Network, Expanding Offering to Patients

Friday, May 14, 2021 - 3:05pm

today announced that they will partner to deploy artificial-intelligence (AI)-based trial matching solution, VIPER\xe2\x84\xa2, into the New Jersey-based cancer network.

Key Points: 
  • today announced that they will partner to deploy artificial-intelligence (AI)-based trial matching solution, VIPER\xe2\x84\xa2, into the New Jersey-based cancer network.
  • The Deep Lens\xe2\x80\x99 VIPER platform uses proprietary cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process.
  • Like Oncology and Hematology Specialists, P.A., any practice that utilizes OncoEMR can easily integrate VIPER and all other Deep Lens screening services free of charge.\nOncology and Hematology Specialists P.A.
  • Growing with sponsors, providers, and strategic partners, Deep Lens challenges the status quo so that patients can get the best therapies.